EAACI Congress 2025
BackL-FT03 - Asthma
Friday 13 Jun, 12:00 PM -
13:00 PM Glasgow, United Kingdom
Dochart 1
Flash Talks
12:00
Whole blood gene expression signatures of children with asthma and allergic sensitisation
12:07
A promising alternative to monoclonal antibody therapy for the treatment of severe Asthma – a Capsid virus-like particle-based vaccine displaying AI-generated TSLP antigens
12:14
The Perfect Storm: Temporal analysis of air during the world’s most deadly epidemic thunderstorm asthma event
12:21
Mepolizumab's Safety and Efficacy in Children and Adolescents with Severe Eosinophilic Asthma: A Real-World Perspective
12:28
Impulse Oscillometry in Children: GAMLSS-Derived Predictive Equations and Post-Bronchodilation Variability
12:35
Comparison of Serum Periostin and IL-13 Levels in Positive and Negative Wheezing Children According to the Asthma Predictive Index and Healthy Controls
12:42
Baseline Type 2 Biomarkers and Mucus Plug Response in Patients With Uncontrolled Moderate-to-Severe Asthma Treated With Dupilumab in the VESTIGE Study
12:49
The association of childhood lung function trajectories with asthma: Results from the Portuguese population-based birth cohort
